| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |